Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women’s Health Initiative: A Longitudinal Study from the United States

PLoS Medicine

Volumn 13, Issue 8, 2016, Pages

  Arnold, Melina ^a   Jiang, Luohua ^b   Stefanick, Marcia L ^c   Johnson, Karen C ^d   Lane, Dorothy S ^e   LeBlanc, Erin S ^f   Prentice, Ross ^g   Rohan, Thomas E ^h   Snively, Beverly M ⁱ   Vitolins, Mara ⁱ   Zaslavsky, Oleg ^j   Soerjomataram, Isabelle ^a   Anton Culver, Hoda ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f CENTER FOR HEALTH RESEARCH   (United States)

^g USA   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF HAIFA   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; SMOKING; UNITED STATES; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; MULTICENTER STUDY; NEOPLASMS; PREGNANCY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; BODY MASS INDEX; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEOPLASMS; OBESITY; OVERWEIGHT; PREGNANCY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84988963525     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1002081     Document Type: Article

References (38)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260. doi: 10.1016/S0140-6736(12)61766-823245609
2. Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012;10:22. doi: 10.1186/1478-7954-10-2223167948
3. Preston SH, Stokes A, Contribution of obesity to international differences in life expectancy. Am J Public Health. 2011;101:2137–2143. doi: 10.2105/AJPH.2011.30021921940912
4. Chang SH, Pollack LM, Colditz GA, Life years lost associated with obesity-related diseases for U.S. non-smoking adults. PLoS ONE. 2013;8:e66550. doi: 10.1371/journal.pone.006655023823705
5. Prospective Studies CollaborationWhitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–1096. doi: 10.1016/S0140-6736(09)60318-419299006
6. Arnold M, Pandeya N, Byrnes G, Renehan AG, Stevens GA, Ezzati M, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16:36–46. doi: 10.1016/S1470-2045(14)71123-425467404
7. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M, Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–578. doi: 10.1016/S0140-6736(08)60269-X18280327
8. World Cancer Research FundAmerican Institute for Cancer ResearchFood, nutrition, physical activity and the prevention of cancer: a global perspective. Washington (District of Columbia):American Institute for Cancer Research; 2007. 517 p.
9. Abdullah A, Wolfe R, Stoelwinder JU, de Courten M, Stevenson C, Walls HL, et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol. 2011;40:985–996. doi: 10.1093/ije/dyr01821357186
10. Abdullah A, Amin FA, Stoelwinder J, Tanamas SK, Wolfe R, Barendregt J, et al. Estimating the risk of cardiovascular disease using an obese-years metric. BMJ Open. 2014;4:e005629. doi: 10.1136/bmjopen-2014-00562925231490
11. Abdullah A, Stoelwinder J, Shortreed S, Wolfe R, Stevenson C, Walls H, et al. The duration of obesity and the risk of type 2 diabetes. Public Health Nutr. 2011;14:119–126. doi: 10.1017/S136898001000181320587115
12. Stolzenberg-Solomon RZ, Schairer C, Moore S, Hollenbeck A, Silverman DT, Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. Am J Clin Nutr. 2013;98:1057–1065. doi: 10.3945/ajcn.113.05812323985810
13. Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative Study Group. Control Clin Trials. 1998;19:61–109. 9492970
14. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, et al. The Women’s Health Initiative recruitment methods and results. Ann Epidemiol. 2003;13(9 Suppl):S18–S77. 14575939
15. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M, The Women’s Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003;13(9 Suppl):S107–S121.
16. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:454–463. doi: 10.1158/1055-9965.EPI-10-097421364029
17. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D, Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599–2608. doi: 10.1056/NEJMoa02503912826634
18. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al. Outcomes ascertainment and adjudication methods in the Women’s Health Initiative. Ann Epidemiol. 2003;13(9 Suppl):S122–S128. 14575944
19. Heo M, Faith MS, Mott JW, Gorman BS, Redden DT, Allison DB, Hierarchical linear models for the development of growth curves: an example with body mass index in overweight/obese adults. Stat Med. 2003;22:1911–1942. doi: 10.1002/sim.121812754724
20. Abdullah A, Wolfe R, Mannan H, Stoelwinder JU, Stevenson C, Peeters A, Epidemiologic merit of obese-years, the combination of degree and duration of obesity. Am J Epidemiol. 2012;176:99–107. doi: 10.1093/aje/kwr52222759723
21. Orsini N, Greenland S, A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. Stata J. 2011;11:1–29.
22. Bianchini F, Kaaks R, Vainio H, Overweight, obesity, and cancer risk. Lancet Oncol. 2002;3:565–574. 12217794
23. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control. 2002;13:741–751. 12420953
24. Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, et al. Estrogen plus progestin and breast cancer incidence and mortality in the Women’s Health Initiative Observational Study. J Natl Cancer Inst. 2013;105:526–535. doi: 10.1093/jnci/djt04323543779
25. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335:1134. doi: 10.1136/bmj.39367.495995.AE17986716
26. Beral V, Bull D, Reeves G, Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2005;365:1543–1551.
27. Beral V, Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362:419–427. 12927427
28. Brinton LA, Richesson D, Leitzmann MF, Gierach GL, Schatzkin A, Mouw T, et al. Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev. 2008;17:3150–3160. doi: 10.1158/1055-9965.EPI-08-043518990757
29. Hou N, Hong S, Wang W, Olopade OI, Dignam JJ, Huo D, Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density. J Natl Cancer Inst. 2013;105:1365–1372. doi: 10.1093/jnci/djt20724003037
30. Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA, Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer. 2004;101:1490–1500. doi: 10.1002/cncr.2049915378477
31. Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the Women’s Health Initiative randomized clinical trials. JAMA Oncol. 2015;1:611–621. doi: 10.1001/jamaoncol.2015.154626182172
32. Reeves KW, Carter GC, Rodabough RJ, Lane D, McNeeley SG, Stefanick ML, et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women’s Health Initiative. Gynecol Oncol. 2011;121:376–382. doi: 10.1016/j.ygyno.2011.01.02721324514
33. Bhaskaran K, Douglas I, Forbes H, Dos-Santos-Silva I, Leon DA, Smeeth L, Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014;384:755–765. doi: 10.1016/s0140-6736(14)60892-825129328
34. Dafni UG, Tsiatis AA, Evaluating surrogate markers of clinical outcome when measured with error. Biometrics. 1998;54:1445–1462. 9883544
35. Moore LL, Bradlee ML, Singer MR, Splansky GL, Proctor MH, Ellison RC, et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord. 2004;28:559–567. doi: 10.1038/sj.ijo.080260614770200
36. Janssen I, Katzmarzyk PT, Ross R, Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379–384. 14985210
37. Decaria JE, Sharp C, Petrella RJ, Scoping review report: obesity in older adults. Int J Obes (Lond). 2012;36:1141–1150. doi: 10.1038/ijo.2012.29
38. Wang Y, Beydoun MA, The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6–28. doi: 10.1093/epirev/mxm00717510091